1. Research Framework for Japan Lung Cancer Market

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2. Research Methodology

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

3. Executive Summary: Japan Lung Cancer Market

Executive Summary: Japan Lung Cancer Market

4. Japan Lung Cancer Market Overview

4.1. Industry Value Chain Analysis
4.1.1. Raw Material Provider
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User

4.2. Industry Outlook
4.2.1. Recent Advances in Clinical Translation of Intra-Articular Osteoarthritis Mobile Phone Insurance
4.2.2. Recent advances in hyaluronic acid-based therapy for osteoarthritis
4.2.3. Patient Data of Osteoarthritis in Japan

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers - Rising Geriatric Population
5.5.1.1. Strict Regulatory Environment
4.5.2. Restraints
4.5.2.1. Strict Regulatory Environment
4.5.3. Opportunity
4.5.3.1. Adoption of AI in Diagnostics and Prognosis
4.5.4. Key Trends

4.6. Market Growth and Outlook
4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2025-2033
4.6.2. Price Trend Analysis

4.7. Competition Dashboard
4.7.1. Market Concentration Rate
4.7.2. Company Market Share Analysis (Value %), 2024
4.7.3. Competitor Mapping & Benchmarking

5. Japan Lung Cancer Market Analysis, By Diagnostics & Therapy 

5.1. Key Insights

5.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
5.2.1. Diagnostics 
5.2.1.1. Bronchoscopy 
5.2.1.2. TTNA 
5.2.1.3. Imaging 
5.2.1.4. Tumor Biomarker Test
5.2.1.5. In Situ Hybridization
5.2.1.6. Others 
5.2.2. Therapy 
5.2.2.1. Non-invasive 
5.2.2.1.1. Immunotherapy 
5.2.2.1.2. Targeted therapy
5.2.2.1.3. Chemotherapy 
5.2.2.1.4. Radiation Therapy
5.2.2.2. Minimally invasive
5.2.2.2.1. Radiofrequency ablation
5.2.2.2.2. Microwave ablation
5.2.2.2.3. Thermal/cryoablation
5.2.2.2.4. Others
5.2.2.3. Surgery
5.2.2.3.1. Thoracotomy
5.2.2.3.2. Lobectomy
5.2.2.3.3. Sleeve Resection
5.2.2.3.4. Segmentectomy
5.2.2.3.5. Pneumenectomy

6. Japan Lung Cancer Market Analysis, By Cancer Type

6.1. Key Insights

6.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
6.2.1. Small Cell Lung Cancer 
6.2.2. Non-small Cell Lung Cancer 
6.2.3. Lung Carcinoid Tumour

7. Japan Lung Cancer Market Analysis, By End User

7.1. Key Insights

7.2. Market Size and Forecast, 2025 - 2033 (US$ Mn)
7.2.1. Hospitals & Specialty Centre
7.2.2. Diagnostic Laboratories 
7.2.3. Others

8. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

8.1. Accuray Incorporated 
8.2. Intuitive Surgical, Inc. 
8.3. Karl Storz SE & Co. KG 
8.4. Medtronic
8.5. Olympus Corporation 
8.6. Theragenics Corporation 
8.7. AngioDynamics Inc. 
8.8. Dunlee 
8.9. Amoy Diagnostics Co., Ltd
8.10. Medicaroid Corporation 
8.11. Others